Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
CSP.L Share News (CSP)
CSP Share
Price
CSP Share
News
CSP Share
Chat
CSP Share
Trades
CSP
Live RNS
CSP Share
Charts
CSP Broker
Ratings
CSP Directors
Deals
CSP Financial
Diary
CSP
Fundamentals
CSP Short
Positions
CSP
Media
CSP Company
Research
CSP Company
Timeline
- There is currently no data for CSP
Wednesday broker round-up
Barclays: Berenberg reiterates buy with a target price of 220p.
Aston Martin: Citigroup reiterates buy with a target price of 2,800p.
Segro: JP Morgan reiterates neutral with a target price of 1,195p.
Sainsbury: Barclays reiterates overweight with a target price of 305p.
GlaxoSmithKline: Liberum reiterates buy with a target price of 1,700p.
On The Beach: Liberum reiterates hold with a target price of 380p.
888 Holdings: Peel Hunt reiterates buy with a target price of 500p.
Countryside Properties: Peel Hunt reiterates buy with a target price of 560p.
Redrow: Numis reiterates buy with a target price of 715p.
Accesso: Numis upgrades to buy with a target price of 800p.
International Airlines Group: Credit Suisse reiterates outperform with a target price of 256p.
Centrica: Credit Suisse reiterates outperform with a target price of 70p.
Latest CSP News
- FTSE 250 movers: Banks, housebuilders soar; Future falls
13 Dec 2019 - LONDON MARKET OPEN: Banks, Homebuilders, Utilities Celebrate Tory Win
13 Dec 2019 - UK Dividends Calendar - Next 7 Days
12 Dec 2019 - UK BROKER RATINGS SUMMARY: Goldman Cuts St James's Place To Sell
29 Nov 2019 - Tuesday broker round-up
26 Nov 2019 - UK BROKER RATINGS SUMMARY: HSBC Upgrades Hiscox; Citigroup Cuts Aviva
26 Nov 2019 - UK BROKER RATINGS SUMMARY: Aviva And Berkeley Group Suffer Downgrades
22 Nov 2019 - TOP NEWS: Countryside Reports Strong Year As CEO Sutcliffe Steps Down
21 Nov 2019
Related News
GSK, Hansoh's targeted cancer drug hits main survival goal in China trial
* GSK partner Hansoh reports first late-stage data for experimental lung cancer drug
GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial
(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or ...
GSK hails 'milestone' drug trial results in China
(Sharecast News) - A targeted lung cancer treatment developed by GSK has shown promising results in the latest trials in China, the pharma blue chip c...
CSP.L News
FTSE 250 movers: Banks, housebuilders soar; Future falls
(Sharecast News) - London's FTSE 250 soared 3.54% higher at 21,529.72 in afternoon trade on Friday, as investors digested the impact of a resounding C...
LONDON MARKET OPEN: Banks, Homebuilders, Utilities Celebrate Tory Win
LONDON MARKET OPEN: Banks, Homebuilders, Utilities Celebrate Tory Win
UK BROKER RATINGS SUMMARY: Goldman Cuts St James's Place To Sell
UK BROKER RATINGS SUMMARY: Goldman Cuts St James's Place To Sell
Tuesday broker round-up
(Sharecast News) - Hiscox: HSBC upgrades to buy with a target price of 1,465p.
UK BROKER RATINGS SUMMARY: HSBC Upgrades Hiscox; Citigroup Cuts Aviva
UK BROKER RATINGS SUMMARY: HSBC Upgrades Hiscox; Citigroup Cuts Aviva
UK BROKER RATINGS SUMMARY: Aviva And Berkeley Group Suffer Downgrades
UK BROKER RATINGS SUMMARY: Aviva And Berkeley Group Suffer Downgrades
TOP NEWS: Countryside Reports Strong Year As CEO Sutcliffe Steps Down
TOP NEWS: Countryside Reports Strong Year As CEO Sutcliffe Steps Down
Follow the stocks
